Phase I Dose Escalation Study of the Pharmacokinetics, Safety and Tolerability of Rifapentine and the Effects of Increasing Doses of Rifapentine on Induction of Metabolizing Enzymes in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 10 Mar 2014
At a glance
- Drugs Midazolam; Rifampicin; Rifapentine
- Indications Seizures; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 10 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Mar 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.